Skip to main content
ImmuneCited

Resveratrol için Chronic Inflammation

C

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Sonuç

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

Key Study Findings

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

In Vitro
Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway.
Dose: None vs: LPS-induced septic mouse model vs control Outcome: IL-1β secretion and NLRP3 inflammasome activation Etki: None None

Popülasyon: Macrophages and LPS-induced septic mouse model

Other
Gut microbiota-metabolite crosstalk mediates icariin's protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli …
Dose: None vs: HFD mouse model vs control Outcome: Testicular morphology and spermatogenesis markers Etki: None None

Popülasyon: HFD-induced obese mouse model (spermatogenesis)

Key Statistics

5

Çalışmalar

300

Katılımcılar

Positive

C

Derece

Referenced Papers

Voprosy pitaniia 2023 19 atıf
Cancer investigation 2023 6 atıf
European journal of … 2020 91 atıf
International journal of … 2018 248 atıf
Current medicinal chemistry 2018 13 atıf
Current pharmacology reports 2015
Current drug targets 2006 92 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
150-500 mg/day
immunesupport:
250-500 mg/day trans-resveratrol

Üst sınır: No established UL; generally well-tolerated up to 1,500 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

En iyi alım zamanı: With meals

Safety & Side Effects

Bildirilen Yan Etkiler

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Joint pain at very high doses (>2.5 g/day)
  • Kidney issues at extremely high doses (case reports)

Bilinen Etkileşimler

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • CYP1A2, CYP3A4 substrates (may inhibit metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

Tolere edilebilir üst alım: No established UL; generally well-tolerated up to 1,500 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Resveratrol help with Chronic Inflammation?
Based on 5 studies with 300 participants, there is limited but promising evidence that Resveratrol may support Chronic Inflammation management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 150-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Joint pain at very high doses (>2.5 g/day), Kidney issues at extremely high doses (case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Chronic Inflammation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.